DKK1 and plasma cell myeloma: The WNT mediated osteoblast inhibition has been shown to be implicated in bone metastasis from multiple myeloma patients where high levels of Dkk-1 a known WNT antagonist leads to impaired osteoblast function and lytic bone lesions32.